Obesity and non-alcoholic fatty liver disease in chronic hepatitis C. 2004

Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, Virginia 22042, USA. zobair.younossi@inova.com

BACKGROUND Superimposed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) may affect HCV-related fibrosis. We performed a study to determine the relationship between NAFLD and chronic hepatitis C. METHODS One hundred and twenty patients with chronic hepatitis C and available liver biopsies were included. Baseline liver biopsies were read by 1 hepatopathologist using Metavir, as well as a fatty liver pathology protocol. Patients' baseline clinical, demographic, and virologic data were associated with the extent of steatosis (>33% vs. < or =33%), the type of fatty liver (no steatosis vs. steatosis only vs. NASH), and the stage of fibrosis seen on the liver biopsy. RESULTS Seventy percent of patients were men and 80% were white. The mean age was 47.48+/-5.70 years, mean BMI was 29.01 +/-5.01 kg/m, and mean waist to hip ratio (W/H) was 0.90+/-0.08. Patients with higher grade of steatosis had higher BMI (32.83+/-6.26 vs. 28.49+/-4.62, P = 0.034), more likely to have genotype 3 (21.4% vs. 5.7%, P = 0.037) and advanced fibrosis (92.9% vs. 62.3%, P = 0.033) than those with lower grade of steatosis. Of these, only HCV-genotype 3 remained independently associated with higher grade of steatosis. When patients with superimposed NASH (n = 22) were compared with those with only steatosis (n = 49) and those without steatosis (n = 49), patients with superimposed NASH had more evidence of obesity (BMI: 30.64+/-5.23 vs. 29.90+/-5.35 vs. 27.33+/-4.07, P = 0.008; W/H: 0.97+/-0.06 vs. 0.91+/-0.08 vs. 0.87+/-0.07, P < 0.001), more commonly infected with HCV genotype 3 (14% vs. 12% vs. 0%, P = 0.036) and had more advanced fibrosis (95.5% vs. 75.5% vs. 42.9%, P < 0.001). Race, gender, and age did not affect extent of steatosis or presence of superimposed NASH. CONCLUSIONS In conclusion, markers of obesity (BMI and W/H) and HCV genotype 3 are associated with the extent of steatosis and type of fatty liver. Higher grade of steatosis and presence of superimposed NASH are both associated with advanced hepatic fibrosis.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
June 2006, Minerva gastroenterologica e dietologica,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
January 2011, PloS one,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
January 2020, World journal of gastroenterology,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
March 2009, Journal of the Formosan Medical Association = Taiwan yi zhi,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
July 2016, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
February 1993, Revista medica de Chile,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
January 2022, Annals of hepatology,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
April 2007, Indian journal of pediatrics,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
January 2021, Archives of disease in childhood,
Zobair M Younossi, and Arthur J McCullough, and Janus P Ong, and David S Barnes, and Anthony Post, and Anthony Tavill, and Diane Bringman, and Lisa M Martin, and Jennifer Assmann, and Terry Gramlich, and Kevin D Mullen, and Robert O'Shea, and William D Carey, and Roy Ferguson
January 2014, Journal of clinical and diagnostic research : JCDR,
Copied contents to your clipboard!